Disseminated mucocutaneous trichosporonosis in a patient with histiocytic sarcoma

An Bras Dermatol. 2021 Sep-Oct;96(5):595-597. doi: 10.1016/j.abd.2021.01.003. Epub 2021 Jul 18.

Abstract

Trichosporon asahii is the causal agent of trichosporonosis. Patients with immunosuppression or hematological malignancies are at higher risk of infection. Skin and mucosal involvement appear as fast-growing papulonodular lesions and necrotic ulcers. Internal organ dissemination is lethal. Therapeutic success depends on the underlying disease. Here, the authors present the first case of disseminated mucocutaneous trichosporonosis in a patient with a post-mortem diagnosis of histiocytic sarcoma, a rare and aggressive haematolymphoid neoplasm. Regretfully, death occurred despite treatment with liposomal amphotericin B and supportive measures, showcasing the fatality of both diseases.

Keywords: Hematologic neoplasms; Histiocytic sarcoma; Trichosporon; Trichosporonosis; Ulcer.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Basidiomycota
  • Histiocytic Sarcoma* / drug therapy
  • Humans
  • Trichosporon*
  • Trichosporonosis* / diagnosis
  • Trichosporonosis* / drug therapy

Substances

  • Antifungal Agents

Supplementary concepts

  • Trichosporon asahii